Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Consensus Rating1
Buy
Highest Price Target1
$60.00
Lowest Price Target1
$40.00
Consensus Price Target1
$51.42
AtriCure Inc has a consensus price target of $51.42 based on the ratings of 13 analysts. The high is $60 issued by JMP Securities on April 30, 2025. The low is $40 issued by JP Morgan on October 30, 2024. The 3 most-recent analyst ratings were released by UBS, Canaccord Genuity, and Canaccord Genuity on July 28, 2026, May 6, 2026, and February 18, 2026, respectively. With an average price target of $52.67 between UBS, Canaccord Genuity, and Canaccord Genuity, there's an implied 33.88% upside for AtriCure Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for AtriCure (NASDAQ:ATRC) was reported by UBS on July 28, 2026. The analyst firm set a price target for $50.00 expecting ATRC to rise to within 12 months (a possible 27.10% upside). 10 analyst firms have reported ratings in the last year.
The latest analyst rating for AtriCure (NASDAQ:ATRC) was provided by UBS, and AtriCure maintained their buy rating.
The last upgrade for AtriCure Inc happened on April 23, 2024 when Oppenheimer raised their price target to $32. Oppenheimer previously had a perform for AtriCure Inc.
The last downgrade for AtriCure Inc happened on February 18, 2026 when Oppenheimer changed their price target from N/A to N/A for AtriCure Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AtriCure, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AtriCure was filed on July 28, 2026 so you should expect the next rating to be made available sometime around July 28, 2027.
While ratings are subjective and will change, the latest AtriCure (ATRC) rating was a maintained with a price target of $55.00 to $50.00. The current price AtriCure (ATRC) is trading at is $39.34, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Buy Now | Get Alert | ||||||
|---|---|---|---|---|---|---|---|
| 07/28/2026 | Buy Now | 27.1% | UBS | $55 → $50 | Maintains | Buy | Get Alert |
| 05/06/2026 | Buy Now | 39.81% | Canaccord Genuity | $53 → $55 | Maintains | Buy | Get Alert |
| 02/18/2026 | Buy Now | 34.72% | Canaccord Genuity | $64 → $53 | Maintains | Buy | Get Alert |
| 02/18/2026 | Buy Now | 39.81% | UBS | $60 → $55 | Maintains | Buy | Get Alert |
| 02/18/2026 | Buy Now | 32.18% | Citizens | $60 → $52 | Maintains | Market Outperform | Get Alert |
| 02/18/2026 | Buy Now | — | Oppenheimer | — | Downgrade | Outperform → Perform | Get Alert |
| 02/18/2026 | Buy Now | 37.26% | BTIG | $54 → $54 | Reiterates | Buy → Buy | Get Alert |
| 02/12/2026 | Buy Now | 14.39% | Needham | $45 → $45 | Reiterates | Buy → Buy | Get Alert |
| 12/16/2025 | Buy Now | 22.01% | JP Morgan | $42 → $48 | Maintains | Overweight | Get Alert |
| 10/30/2025 | Buy Now | 62.68% | Canaccord Genuity | $53 → $64 | Maintains | Buy | Get Alert |
| 07/30/2025 | Buy Now | 14.39% | Needham | $44 → $45 | Maintains | Buy | Get Alert |
| 04/30/2025 | Buy Now | 32.18% | BTIG | $58 → $52 | Maintains | Buy | Get Alert |
| 04/30/2025 | Buy Now | 47.43% | UBS | $60 → $58 | Maintains | Buy | Get Alert |
| 04/30/2025 | Buy Now | 52.52% | JMP Securities | $60 → $60 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/30/2025 | Buy Now | 11.85% | Needham | $51 → $44 | Maintains | Buy | Get Alert |
| 04/02/2025 | Buy Now | 52.52% | Citizens Capital Markets | $60 → $60 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/28/2025 | Buy Now | 32.18% | Canaccord Genuity | $66 → $52 | Maintains | Buy | Get Alert |
| 03/27/2025 | Buy Now | 47.43% | BTIG | $57 → $58 | Maintains | Buy | Get Alert |
| 03/27/2025 | Buy Now | 16.93% | JP Morgan | $51 → $46 | Maintains | Overweight | Get Alert |
| 03/27/2025 | Buy Now | 29.64% | Needham | $51 → $51 | Reiterates | Buy → Buy | Get Alert |
| 03/21/2025 | Buy Now | 29.64% | Needham | $51 → $51 | Reiterates | Buy → Buy | Get Alert |
| 02/13/2025 | Buy Now | 44.89% | BTIG | $53 → $57 | Maintains | Buy | Get Alert |
| 02/13/2025 | Buy Now | 14.39% | Oppenheimer | $36 → $45 | Maintains | Outperform | Get Alert |
| 02/13/2025 | Buy Now | 27.1% | Piper Sandler | $40 → $50 | Maintains | Overweight | Get Alert |
| 02/13/2025 | Buy Now | 52.52% | JMP Securities | $60 → $60 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/13/2025 | Buy Now | 22.01% | Stifel | $36 → $48 | Maintains | Buy | Get Alert |
| 02/13/2025 | Buy Now | 29.64% | Needham | $51 → $51 | Reiterates | Buy → Buy | Get Alert |
| 02/13/2025 | Buy Now | 67.77% | Canaccord Genuity | $61 → $66 | Maintains | Buy | Get Alert |
| 02/11/2025 | Buy Now | 29.64% | JP Morgan | $40 → $51 | Maintains | Overweight | Get Alert |
| 02/10/2025 | Buy Now | 52.52% | JMP Securities | $60 → $60 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 01/22/2025 | Buy Now | 29.64% | Needham | $40 → $51 | Maintains | Buy | Get Alert |
| 01/13/2025 | Buy Now | 1.68% | Needham | $40 → $40 | Reiterates | Buy → Buy | Get Alert |
| 12/17/2024 | Buy Now | 1.68% | JP Morgan | → $40 | Assumes | → Overweight | Get Alert |
| 12/09/2024 | Buy Now | 55.06% | Canaccord Genuity | $53 → $61 | Maintains | Buy | Get Alert |
| 10/30/2024 | Buy Now | 34.72% | Canaccord Genuity | $49 → $53 | Maintains | Buy | Get Alert |
| 10/30/2024 | Buy Now | -8.49% | Oppenheimer | $32 → $36 | Maintains | Outperform | Get Alert |
| 10/30/2024 | Buy Now | 1.68% | JP Morgan | $30 → $40 | Maintains | Overweight | Get Alert |
| 10/30/2024 | Buy Now | 1.68% | UBS | $35 → $40 | Maintains | Buy | Get Alert |
| 10/30/2024 | Buy Now | 1.68% | Needham | $34 → $40 | Maintains | Buy | Get Alert |
| 07/31/2024 | Buy Now | 34.72% | BTIG | $58 → $53 | Maintains | Buy | Get Alert |
| 07/31/2024 | Buy Now | -23.74% | JP Morgan | $34 → $30 | Maintains | Overweight | Get Alert |
| 07/31/2024 | Buy Now | -33.91% | Stifel | $30 → $26 | Maintains | Buy | Get Alert |
| 07/31/2024 | Buy Now | 1.68% | Piper Sandler | $65 → $40 | Maintains | Overweight | Get Alert |
| 07/31/2024 | Buy Now | -13.57% | Needham | $40 → $34 | Maintains | Buy | Get Alert |
| 07/08/2024 | Buy Now | 1.68% | Needham | $40 → $40 | Reiterates | Buy → Buy | Get Alert |
| 05/02/2024 | Buy Now | 24.56% | Canaccord Genuity | $57 → $49 | Maintains | Buy | Get Alert |
| 05/02/2024 | Buy Now | -13.57% | JP Morgan | $42 → $34 | Maintains | Overweight | Get Alert |
| 05/02/2024 | Buy Now | 1.68% | Needham | $46 → $40 | Maintains | Buy | Get Alert |
| 04/23/2024 | Buy Now | -18.66% | Oppenheimer | → $32 | Upgrade | Perform → Outperform | Get Alert |
| 04/10/2024 | Buy Now | 16.93% | Needham | $46 → $46 | Reiterates | Buy → Buy | Get Alert |
| 02/16/2024 | Buy Now | 47.43% | UBS | $57 → $58 | Maintains | Buy | Get Alert |
| 02/16/2024 | Buy Now | 6.76% | Stifel | $50 → $42 | Maintains | Buy | Get Alert |
| 02/16/2024 | Buy Now | 16.93% | Needham | $44 → $46 | Maintains | Buy | Get Alert |
| 01/22/2024 | Buy Now | 44.89% | UBS | $56 → $57 | Maintains | Buy | Get Alert |
| 01/04/2024 | Buy Now | 11.85% | Needham | $49 → $44 | Maintains | Buy | Get Alert |
| 11/29/2023 | Buy Now | 52.52% | JMP Securities | → $60 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/29/2023 | Buy Now | 24.56% | Needham | → $49 | Reiterates | Buy → Buy | Get Alert |
| 11/02/2023 | Buy Now | 27.1% | JP Morgan | $60 → $50 | Maintains | Overweight | Get Alert |
| 11/02/2023 | Buy Now | 24.56% | Needham | $68 → $49 | Maintains | Buy | Get Alert |
| 10/23/2023 | Buy Now | 52.52% | JMP Securities | → $60 | Initiates | → Market Outperform | Get Alert |
| 09/29/2023 | Buy Now | 42.35% | UBS | → $56 | Initiates | → Buy | Get Alert |